To Study the Effect of Early Cooling in Acute Subdural Hematoma Patients

NCT ID: NCT02064959

Last Updated: 2020-10-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-03-22

Study Completion Date

2019-02-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized, prospective trial will study the effect of very early cooling in patients undergoing surgical evacuation of acute subdural hematomas (35°C prior to opening the dura followed by maintenance at 33°C for a minimum of 48h). Intravascular cooling catheters (Thermogard XP Device, Zoll) will be utilized to induce hypothermia or to maintain normothermia.

The primary objective is to determine if rapid induction of hypothermia prior to emergent craniotomy for traumatic subdural hematoma (SDH) will improve outcome as measured by Glasgow Outcome Scale-Extended (GOSE) at 6 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subdural Hematoma, Traumatic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hypothermia

Hypothermia to 33°C

Group Type EXPERIMENTAL

Temperature management Zoll Intravascular Temperature Management device

Intervention Type DEVICE

Normothermia

standard care - normothermia (37°C)

Group Type ACTIVE_COMPARATOR

Temperature management Zoll Intravascular Temperature Management device

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Temperature management Zoll Intravascular Temperature Management device

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non-penetrating traumatic brain injury
* Glasgow Coma Scale (GCS) motor score ≤5 (not following commands)
* Estimated or known age 22-65 years
* Acute subdural hematoma requiring emergent craniotomy within 6 hours of initial injury
* Estimated time of injury to time to reach temp of 35°C\<6 hrs

Exclusion Criteria

* Total GCS = 3 and bilateral fixed and dilated pupils
* Following commands after an initial period of coma (GSC motor score of 6)
* Known pre-existing neurological deficit (e.g., previous traumatic brain injury (TBI), stroke)
* Concomitant spinal cord injury
* Arrival temperature is \<35°C
* Hemodynamic instability (i.e., mean arterial pressure (MAP)\<60 millimetres of mercury (mmHg) for 30 minutes)
* Active cardiac dysrhythmia resulting in hemodynamic instability
* Pregnancy
* Duret hemorrhage
* Prisoner or Ward of the State
* Known history of clotting disorder (e.g., heparin induced thrombocytopenia, pulmonary embolism/deep venous thrombosis)
* Injury to other body organ where hypothermia would be precluded because of bleeding risk (e.g., grade 3 liver laceration; bowel laceration; flail lung or international normalized ratio (INR) \>1.4)
* Inability to obtain informed consent or utilize exception to informed consent for emergency research.
Minimum Eligible Age

22 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Vivian L. Smith Center for Neurologic Research

OTHER

Sponsor Role collaborator

Zoll Medical Corporation

INDUSTRY

Sponsor Role collaborator

The University of Texas Health Science Center, Houston

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dong Kim

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dong H. Kim, MD

Role: STUDY_CHAIR

The University of Texas Health Science Center, Houston

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University off Miami and Ryder Trauma Center, Jackson Memorial Hospital

Miami, Florida, United States

Site Status

Emory University

Atlanta, Georgia, United States

Site Status

University of Cincinnati

Cincinnati, Ohio, United States

Site Status

The University of Pittsburgh Medical Center and UPMC Presbyterian

Pittsburgh, Pennsylvania, United States

Site Status

The University of Texas at Houston Medical School and Memorial Hermann Hospital

Houston, Texas, United States

Site Status

Kurume University Hospital

Fukuoka, , Japan

Site Status

Saiseikai Fukuoka General Hospital

Fukuoka, , Japan

Site Status

Kagawa University Hospital

Kagawa, , Japan

Site Status

Nagasaki University Hospital

Nagasaki, , Japan

Site Status

Osaka Mishima Emergency Critical Care Center

Osaka, , Japan

Site Status

National Disaster Medical Center

Tokyo, , Japan

Site Status

Nippon Medical School Hospital

Tokyo, , Japan

Site Status

Nippon Medical School Tamanagayama Hospital

Tokyo, , Japan

Site Status

Yamaguchi University Hospital

Yamaguchi, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Japan

References

Explore related publications, articles, or registry entries linked to this study.

Hergenroeder GW, Yokobori S, Choi HA, Schmitt K, Detry MA, Schmitt LH, McGlothlin A, Puccio AM, Jagid J, Kuroda Y, Nakamura Y, Suehiro E, Ahmad F, Viele K, Wilde EA, McCauley SR, Kitagawa RS, Temkin NR, Timmons SD, Diringer MN, Dash PK, Bullock R, Okonkwo DO, Berry DA, Kim DH. Hypothermia for Patients Requiring Evacuation of Subdural Hematoma: A Multicenter Randomized Clinical Trial. Neurocrit Care. 2022 Apr;36(2):560-572. doi: 10.1007/s12028-021-01334-w. Epub 2021 Sep 13.

Reference Type DERIVED
PMID: 34518968 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HSC-MS-12-0762

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mild Hypothermia in Acute Ischemic Stroke
NCT00987922 COMPLETED PHASE2
Prehospital COOLing 1 (PreCOOL 1)
NCT01669408 UNKNOWN PHASE2